1312 — Kontafarma China Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Kontafarma China Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	236	195	184	143	87.7
Net Total Accounts Receivable
Net Total Receivables	1,516	439	402	379	395
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,010	783	781	690	588
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,189	988	1,110	801	574
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	4,000	2,542	2,559	2,120	1,727
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,591	632	703	505	384
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	2,588	1,328	1,367	1,019	670
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	1,412	1,214	1,192	1,101	1,057
Total Liabilities & Shareholders' Equity	4,000	2,542	2,559	2,120	1,727
Total Common Shares Outstanding